Your browser doesn't support javascript.
loading
Targeting the STAT5A/IDO1 axis overcomes radioresistance and reverses the immunosuppressive tumor microenvironment in NSCLC.
Yang, Yang; Zheng, Xiaoli; Ni, Peizan; Li, Dingjie; Dan, Qinfu; Wang, Xiaohui; Wang, Yunhan; Sun, Yanan; Liu, Kangdong; Dong, Zigang; Ge, Hong.
Affiliation
  • Yang Y; Department of Radiation Oncology, The Affiliated Cancer Hospital of Zhengzhou University and Henan Cancer Hospital, Zhengzhou, Henan 450008, P.R. China.
  • Zheng X; Department of Radiation Oncology, The Affiliated Cancer Hospital of Zhengzhou University and Henan Cancer Hospital, Zhengzhou, Henan 450008, P.R. China.
  • Ni P; Department of Radiation Oncology, The Affiliated Cancer Hospital of Zhengzhou University and Henan Cancer Hospital, Zhengzhou, Henan 450008, P.R. China.
  • Li D; Department of Radiation Oncology, The Affiliated Cancer Hospital of Zhengzhou University and Henan Cancer Hospital, Zhengzhou, Henan 450008, P.R. China.
  • Dan Q; Department of Radiation Oncology, The Affiliated Cancer Hospital of Zhengzhou University and Henan Cancer Hospital, Zhengzhou, Henan 450008, P.R. China.
  • Wang X; Department of Radiation Oncology, The Affiliated Cancer Hospital of Zhengzhou University and Henan Cancer Hospital, Zhengzhou, Henan 450008, P.R. China.
  • Wang Y; Department of Radiation Oncology, The Affiliated Cancer Hospital of Zhengzhou University and Henan Cancer Hospital, Zhengzhou, Henan 450008, P.R. China.
  • Sun Y; Department of Radiation Oncology, The Affiliated Cancer Hospital of Zhengzhou University and Henan Cancer Hospital, Zhengzhou, Henan 450008, P.R. China.
  • Liu K; Department of Pathophysiology, China­US (Henan) Hormel Cancer Institute, Zhengzhou, Henan 450008, P.R. China.
  • Dong Z; Department of Pathophysiology, China­US (Henan) Hormel Cancer Institute, Zhengzhou, Henan 450008, P.R. China.
  • Ge H; Department of Radiation Oncology, The Affiliated Cancer Hospital of Zhengzhou University and Henan Cancer Hospital, Zhengzhou, Henan 450008, P.R. China.
Int J Oncol ; 62(1)2023 Jan.
Article in En | MEDLINE | ID: mdl-36453241

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Non-Small-Cell Lung / Lung Neoplasms Type of study: Prognostic_studies Limits: Animals Language: En Journal: Int J Oncol Journal subject: NEOPLASIAS Year: 2023 Document type: Article Country of publication: Greece

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Non-Small-Cell Lung / Lung Neoplasms Type of study: Prognostic_studies Limits: Animals Language: En Journal: Int J Oncol Journal subject: NEOPLASIAS Year: 2023 Document type: Article Country of publication: Greece